GSK_WRN3 is selective WRN helicase inhibitor (pIC50 = 8.6). SK_WRN3 can selectively inhibit the growth of microsatellite unstable (MSI) cancer cells, induce DNA damage, and cause cell cycle arrest. GSK_WRN3 has anti-tumor activity[1].
Molecular Weight:
352.41
Purity:
98.54
CAS Number:
[2923009-50-9]
Formula:
C16H20N2O5S
Target:
ATM/ATR,DNA/RNA Synthesis
Application Notes:
MCE Product type: Reference compound1
* VAT and and shipping costs not included. Errors and price changes excepted